DON'T MISS

On July 29, 2015, Sanofi (NYSE:SNY) announced that it had met the primary endpoint in its phase 3 study of LixiLan, a combination treatment...

An hour before market open in the US on Tuesday, Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) announced that one of its candidates had received US Food...

Stock News & Insights

In October last year, DBV Technologies (NASDAQ:DBVT) hit the markets with a pretty disappointing IPO, closing out at an average of around $21 per...

At the end of last week, we learned that Denmark based Novo Nordisk A/S (ADR) (NYSE:NVO) had achieved promising results in its once weekly...

With all the hype surrounding the potential biotech bubble and the flurry of IPOs we've seen over the last few weeks, it is easy...

2015 has been pretty hot year for biotech IPOs. The space as a whole has expanded close to 400% over the past five years,...

Biopharmaceutical incumbent Novartis AG (NYSE:NVS) stock has struggled of late, having had something of a bumper first half of the year, reaching May highs...

Our Featured Authors

27 POSTS0 COMMENTS
2 POSTS0 COMMENTS
0 POSTS0 COMMENTS
1 POSTS0 COMMENTS